# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Idiopathic pulmonary fibrosis

Familial pulmonary fibrosis
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 31-40 of 364 results.
Lung MRI in the Management of Idiopathic Pulmonary Fibrosis
Status: Unknown status
Last Changed: Mar 13, 2017
First Received: Mar 13, 2017
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): MRI, Thoracic HRCT (standard reference)
Locations: CHU de Bordeaux, Pessac, France
Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
Status: Not yet recruiting
Last Changed: Jul 10, 2020
First Received: Apr 27, 2020
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
Locations: The University of Alabama at Birmingham, Birmingham, Alabama, United States
Jaktinib Dihydrochloride Monohydrate in Idiopathic Pulmonary Fibrosis
Status: Recruiting
Last Changed: Sep 16, 2020
First Received: Mar 18, 2020
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): Jaktinib Dihydrochloride Monohydrate 50mg BID and Mimic tablets of jakitinib hydrochloride 75mg BID and Acetylcysteine Effervescent Tablets, Jaktinib Dihydrochloride Monohydrate 75mg BID and Mimic tablets of jakitinib hydrochloride 50mg BID and Acetylcysteine Effervescent Tablets, Placebo oral tablet and Acetylcysteine Effervescent Tablets
Locations: Peking Union Medical College Hospital, Beijing, Beijing, China
Investigating Idiopathic Pulmonary Fibrosis in Greece (INDULGE IPF)
Status: Active, not recruiting
Last Changed: Oct 22, 2020
First Received: Mar 08, 2017
Disease(s): Idiopathic Pulmonary Fibrosis
Locations: Gen. Hosp. of Chest Diseases "Sotiria", Univ. Resp. Med., Athens, Greece
Sotiria Hospital Athens, 7th Pulmonary Clinic, Athens, Greece
University General Hospital Attikon, Athens, Greece
University Hospital of Heraklion, University Pulmonology Cl, Heraklion, Greece
General University Hospital of Larissa, Larissa, Greece
... and 3 other locations.
Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis
Status: Recruiting
Last Changed: Jun 11, 2020
First Received: Dec 16, 2015
Disease(s): Idiopathic Pulmonary Fibrosis
Locations: London Health Science Centre, London, Ontario, Canada
A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
Status: Withdrawn
Last Changed: Jan 05, 2016
First Received: Feb 01, 2012
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): Standard Steroid Treatment, The Standard Steroid Treatment, Plasma Exchange and rituximab
Locations: Geisinger Medical Center, Danville, Pennsylvania, United States
Temple University Medical Center, Philladelphia, Pennsylvania, United States
University of Pittsburgh, Pittsburgh, Pennsylvania, United States
University of Texas Medical Branch - Galveston, Galveston, Texas, United States
Inova Fairfax Heart and Vascular Institute, Falls Church, Virginia, United States
... and 1 other locations.
Idiopathic Pulmonary Fibrosis Job Exposures Study
Status: Completed
Last Changed: Dec 12, 2019
First Received: Jul 07, 2017
Disease(s): IPF, Idiopathic Pulmonary Fibrosis
Intervention(s): Computer-assisted telephone interview, Genetic analysis
Locations: Imperial Healthcare NHS Trust, London, United Kingdom
Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole
Status: Terminated
Last Changed: Nov 14, 2017
First Received: Jan 29, 2013
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): Cotrimoxazole, Placebo
Locations: Hospital Universitario Virgen del Rocío/ Instituto de Biomedicina de Sevilla, Sevilla, Spain
Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry
Status: Completed
Last Changed: Oct 11, 2018
First Received: Oct 08, 2007
Disease(s): Idiopathic Pulmonary Fibrosis
Locations: Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States
Temple University, Philadelphia, Pennsylvania, United States
Dorothy P. & Richard P. Simmons Center for Interstitial Lung Disease, Pittsburgh, Pennsylvania, United States
The Center for Health Research at Giesinger Health System, Wilkes-Barre, Pennsylvania, United States
... and 1 other locations.
Efficacy, Safety and Tolerability of NP-120 on Idiopathic Pulmonary Fibrosis and Its Associated Cough
Status: Recruiting
Last Changed: Jul 08, 2020
First Received: Mar 24, 2020
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): Ifenprodil
Locations: Vale Medical Practice, Brookvale, New South Wales, Australia
Concord Repatriation General Hospital, Concord, New South Wales, Australia
Cairns Hospital, Cairns, Queensland, Australia
The University of Otago, Christchurch, Canterbury, New Zealand
Waikato Hospital, Hamilton, Waikato, New Zealand
... and 1 other locations.